Desk›Chemicals› Titan Biotech Ltd
Titan Biotech Ltd
BSE 524717 · NSE TITANBIO · ISIN INE150C01029 · Group XT · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹379.90
+0.30%
BSE close, 28 August 2026
₹1,569.69 cr
4.1 cr shares · Micro cap
₹544.76 cr
as published
51.1× · 11.41×
EPS ₹7.44 · BV ₹33.30
206.19 / 27.45
₹ cr, as filed
20
3 selected · 15%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -31.6% |
|---|---|
| Against 52-week low | +243.9% |
| Day change | +0.30% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹7.44 |
|---|---|
| Price / earnings | 51.06× |
| Price / book | 11.41× |
| Book value — derived, price ÷ P/B | ₹33.30 |
| Return on equity | 22.35% |
| Operating margin | 24.17% |
| Net margin | 15.98% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 22.35%
- ROE as published
- 22.35%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 59.17 | 9.46 | 2.29 | 24.17% | 15.98% |
| Mar-26 · Q | 48.83 | 6.56 | 1.59 | 24.20% | 13.43% |
| FY25-26 | 206.19 | 27.45 | 6.64 | 21.35% | 13.31% |
Quarter on quarter
- Revenue, quarter on quarter
- +21.2%
- Net profit, quarter on quarter
- +44.2%
- Operating margin, quarter on quarter
- -3 bps
Disclosure profile 20 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| Newspaper Publication | 4 |
| AGM / EGM | 3 |
| Board Meeting | 2 |
| Record Date | 2 |
| Trading Window | 2 |
| Book Closure | 1 |
| Charter Amendment | 1 |
| Compliance Certificate | 1 |
| Corporate Action | 1 |
| Procedural sub-total | 17 |
| Total | 20 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
20 filings · 3 selected · busiest 2026-09-03
Filing rhythm · the twelve most recent
2026-09-032026-10-09
SelectedProcedural
Filings
20 in the window · 3 earlier on record
-
9 October 2026 ·
Intimation Of Record Date And Deemed Date Of Allotment Of Bonus Equity Shares
The Company has fixed record date as Friday, October 23, 2026 for ascertaining the eligibility of Shareholders entitled for allotment of Bonus Equity Shares in the ratio of 1:4 and deemed ....
Corp. Action / Record Date View filing →
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regn 74(5) of SEBI (DP) Regulations, 2018 for quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Amendments to Memorandum & Articles of Association
Alteration of the Clause 5 i.e. Capital Clause of the Memorandum of Association (MOA) of the Company
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results and Scrutinizers Report for 34th Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 34th Annual General Meeting of Titan Biotech Limited
AGM/EGM / AGM View filing →
-
24 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 September 2026 ·
Newspaper Publication
Notice of Loss of Share Certificate-Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 2015
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
Newspaper Publication
Newspaper Publication regarding Notice of 34th Annual General Meeting, E-Voting and other related information
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Newspaper Publication
Newspaper advertisement regarding 34th Annual General Meeting of Titan Biotech Limited through VC/OAVM
Company Update / Newspaper Publication View filing →
-
3 September 2026 ·
Intimation Of Record Date For The Purpose Of Final Dividend
Intimation of record date for the purpose of Dividend to the members of the Company for FY 2025-26.
Corp. Action / Record Date View filing →
-
3 September 2026 ·
Fixation Of Annual General Meeting Date, Record Date, Book Closure Date And E-Voting Date
The 34th Annual General Meeting of the Company scheduled to be held on September 29, 2026 through VC/ OAVM and the Company accordingly fixed Record Date, Book Closure Date and E-Voting Date
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Corporate Action-Fixes Book Closure For 34Th Annual General Meeting Of The Company
Fixation of Annual General Meeting Date, Record Date, Book Closure date and dates for E-Voting
Corp. Action / Book Closure View filing →
-
3 September 2026 ·
Corporate Action-Board recommends Bonus Issue
Recommended the Issuance of Bonus Issue, subject to shareholders approval and any other applicable regulatory and statutory approval, in the ratio of 1:4 .i.e. 1(one) new Fully paid up ....
Corp. Action / Bonus View filing →
-
3 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Dated September 3, 2026
Recommended Issuance of Bonus Shares, subject to shareholders approval and any other applicable regulatory and statutory approval, in ratio of 1:4 i.e. 1(one) new fully paid up Equity Shares ....
Board Meeting / Outcome of Board Meeting View filing →
-
31 August 2026 ·
Board Meeting Intimation for Considering Bonus Issue, Draft AGM Notice, Draft Directors Report, Fix AGM, Decide Cut Off Date, E-Voting Dates, Record Dates, Books Closure And Any Other Items With The Permission Of Chair.
Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 ,inter alia, to consider and approve 1. the proposal of bonus issue, ....
Board Meeting / Board Meeting View filing →
-
31 August 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
14 August 2026 ·
Newspaper Publication
Newspaper publication of the Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2026
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026
Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026 ·
Unaudited Financial Results For Quarter Ended June 2026
Unaudited Financial Results along with the limited review report from the statutory Auditor of the Company for the quarter ended June 2026
Result / Financial Results View filing →
-
5 August 2026 ·
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2026.
Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the standalone and consolidated ....
Board Meeting / Board Meeting View filing →
RSS feed for Titan Biotech Ltd · the 50 most recent filings